Innovation Ventures, LLC v. Custom Nutrition Laboratories, LLC et al
Filing
180
ORDER RESOLVING PENDING MOTIONS. Signed by District Judge Terrence G. Berg. (Chubb, A)
UNITED STATED DISTRICT COURT
EASTERN DISTRICT OF MICHIGAN
SOUTHERN DIVISION
INNOVATION VENTURES, LLC f/d/b/a
LIVING ESSENTIALS, a Michigan
limited liability company,
Plaintiff/Counter-Defendant,
v.
Case No. 12-13850
Hon. Terrence G. Berg
CUSTOM NUTRITION LABORATORIES, LLC,
a Texas limited liability company,
Defendant,
and
NUTRITION SCIENCE LABORATORIES, LLC, a
Texas limited liability company,
and ALAN JONES,
Defendants/Counter-Plaintiffs.
____________________________________________/
ORDER RESOLVING PENDING MOTIONS
This case involves a dispute between Plaintiff Innovation Ventures, LLC,
f/d/b/a Living Essentials (“Plaintiff”), the maker and distributor of the liquid energy
drink “5-Hour Energy” and Defendants, competitors of Plaintiff, over whether
Defendants are using certain ingredients in their energy drinks that they had
allegedly agreed not to use.
Plaintiff manufactures and distributes 5-Hour Energy throughout the United
States. Plaintiff initially contracted with Defendant Custom Nutrition
Laboratories, LLC (“CNL”) to produce and package 5-Hour Energy. At that time,
Defendant Alan Jones (“Jones”) was CNL’s Chief Executive Officer. This is not the
first lawsuit between Plaintiff and Defendants CNL and Jones; they previously sued
each other in the Eastern District of Texas, and reached a settlement agreement in
that case which Plaintiff now claims Defendants are breaching.
Specifically, Defendant Nutrition Science Laboratories, LLC (“NSL”) –
alleged by Plaintiff to be a successor to the now-defunct CNL – currently
manufactures and distributes competing energy drinks containing ingredients that
Plaintiff claims are prohibited under the terms the settlement agreement resolving
the prior litigation between Plaintiff and Defendants CNL and Jones (the
“Settlement Agreement”) (Dkt. 135, Ex. 1).
Before the Court are seven motions: Defendants’ amended motion for partial
summary judgment (Dkt. 141 [initially Dkt. 132]); Plaintiff’s motion for summary
judgment (Dkts. 134 & 135); Defendants’ motion to strike and exclude the expert
opinions of Dr. Steven Zeisel (Dkt. 142); Plaintiff’s motion to strike and exclude the
expert opinions of Dr. J. Thomas Brenna and Alan Jones (Dkt. 149); Defendants’
motion for leave to file motion for extension of time to file response (Dkt. 157);
Defendants’ motion in limine (Dkt. 168); and Plaintiff’s motion for clarification and
renewal of motion for summary judgment (Dkt. 174 [amended by Dkts. 176 & 177]).
As noted earlier, this lawsuit’s core issue is whether Defendants,
manufacturers of liquid energy drinks that compete with Plaintiff’s product “5-hour
Energy,” are in breach of the Settlement Agreement previously reached between
2
Plaintiff and Defendants CNL and Jones that sought, among other things, to
prevent the use of certain ingredients in Defendants’ competing products.
Defendants’ motion for partial summary judgment is founded on the argument that
two substances used by Defendants – “betaine” and “alpha GPC” – are not covered
by the Settlement Agreement’s prohibition (Dkt. 141).
Likewise, Plaintiff’s motion for summary judgment maintains that those two
substances are prohibited, and requests the Court to enter judgment that
Defendants are liable for breaching the Settlement Agreement (Dkt. 134).
Consistent with their diametrically opposed views of the breadth of the Settlement
Agreement, both parties seek to strike and exclude the other side’s expert opinions
being offered to shed light on the Settlement Agreement’s meaning (Dkts. 142, 149).
In light of the centrality of this question, the Court sought to simplify the case by
issuing an order bifurcating the proceedings into liability and damages phases on
May 20, 2013 (Dkt. 111).
Unfortunately, as the parties’ voluminous motion practice has revealed,
neither side can agree on the meaning of the operative clause of that Settlement
Agreement. The disagreement regarding the meaning of this clause undergirds the
arguments in almost all of the pending motions. This disputed clause purports to
list those ingredients which Defendants allegedly agreed not to use in energy
drinks, and states in pertinent part:
No Energy Liquid [sold by Defendants] shall contain anything in
the Choline Family (defined below) . . .
3
The term “Choline Family” means citicoline, choline bitartrate,
bilineurine, Beta-hydroxyethyl, trimethylammonium hydroxide,
choline chloride, choline citrate, cytidine 5-diphosphocholine
(CDP-choline), intrachol, liptropic factor, PhosCholxAE,
phosphatidylcholine,
TRI,
tricholine
citrate
(TRI),
trimethylethanolamine or their equivalents in all forms,
derivatives, constituents, and synthetic equivalents or substitutes;
Taurine is excluded.
(Dkt. 135, Ex. 1, ¶ 5(c)(i)) (emphasis added to identify the “catch-all” phrase as
discussed below). The fact that both parties have submitted hundreds of pages of
briefs and exhibits in an attempt to explain why only their interpretation of these
terms is correct demonstrates that neither side is entitled to summary judgment.
The terms listed in Settlement Agreement’s definition of the “Choline
Family” include both generic chemical compounds as well as the trade names of
certain other compounds, some of which appear to be redundant. In addition to
prohibiting the use of these specified substances, the Settlement Agreement also
prohibits any energy liquid from containing “their equivalents in all forms,
derivatives, constituents, and synthetic equivalents or substitutes.” The intended
scope and meaning of this “catch-all” phrase is unclear; it could be broadly
interpreted to prohibit anything intended as a “substitute” for anything that could
be proven to be a member of the “Choline Family,” or it could be understood to
target only substances falling within certain categories recognized as “equivalents
in all their forms, derivatives, constituents, and synthetic equivalents or
substitutes.”
4
The catch-all terms in this clause are subject to myriad definitions, and the
parties do not even agree as the relevant industry from which such definitions
should be taken.
In one of the seven pending motions, Plaintiff seeks clarification of the
Court’s Order of January 23, 2014, in which the Court stated that the catch-all
clause was ambiguous and set a date for an evidentiary hearing to receive
testimony on its meaning (Dkt. 174). In order to provide clarification, the Court
now GRANTS this motion and holds that the “catch-all” clause of paragraph 5(c)(i)
of the Settlement Agreement1 entered by and between Defendants CNL, Jones and
Plaintiff in resolution of the previous litigation (See Dkt. 135, Ex. 1) is ambiguous as
a matter of law.
Whether a contract’s terms are ambiguous is a question of law for the Court
to determine. See GenCorp, Inc. v. Am. Int'l Underwriters, 178 F.3d 804, 818 (6th
Cir. 1999). A contract is said to be ambiguous when its words may reasonably be
understood in different ways. See Farm Bureau v. Nikkel, 460 Mich. 558, 596
N.W.2d 915, 919 (1999). If the Court finds no ambiguity, it should proceed to
interpret the contract and may do so at the summary judgment stage. See GenCorp,
178 F.3d at 818. If the contract remains ambiguous, then the intent of the parties
becomes a question of fact for a jury. See Manley v. Plasti–Line, Inc., 808 F.2d 468,
471 (6th Cir. 1987) (“[D]isputed questions of contractual intent are considered
factual issues which are precluded from summary resolution”); Klapp v. United Ins.
The Court notes that Defendant NSL previously contended that the Settlement Agreement is not
binding upon it (see, e.g., Dkt. 31 at 8).
1
5
Group Agency, Inc., 468 Mich. 459, 663 N.W.2d 447, 453–54 (2003) (“It is well
settled that the meaning of an ambiguous contract is a question of fact that must be
decided by the jury”).
Consequently, because the catch-all phrase is ambiguous, the question at the
heart of the cross motions for summary judgment, whether the definition of the
term “Choline Family” was intended to include the compounds “betaine” and “alphaGPC,” must be left to the jury.
To summarize the Court’s Order:
Plaintiff’s motion for clarification (Dkt. 174 [amended by Dkts. 176 & 177]) is
GRANTED;
Defendants’ amended motion for partial summary judgment (Dkt. 141
[initially Dkt. 132]) is DENIED, in light of the above ruling.
Plaintiff’s motion for summary judgment (Dkts. 134 & 135 [renewed in Dkt.
174]) is GRANTED IN PART, because Defendants have admitted that their
energy drink products previously contained choline bitartrate and choline citrate,
substances expressly prohibited by name in the Settlement Agreement (see Dkt.
174, Ex. 2). Plaintiff’s motion for summary judgment is DENIED in all other
respects.
However, as stated in footnote one, above, the question of whether the
Settlement Agreement is binding upon Defendant NSL remains to be addressed.
That question may now be considered: Defendant NSL is granted leave to file a
motion for summary judgment focusing on the question whether the Settlement
6
Agreement is binding upon it within fourteen (14) days of the date of this Order,
with response and reply deadlines following the time set forth in E.D. Mich. LR
7.1(e). If Defendant NSL chooses not to file such a summary judgment motion, then
the Court will set this matter for a jury trial.
Other than the above-referenced motion for summary judgment, no further
motions of any kind may be filed by either party without obtaining leave of Court
after the grounds for such motion have been discussed with and approved by the
Court in a status conference.
Further, Defendants’ motion to strike and exclude the expert opinions of Dr.
Steven Zeisel (Dkt. 142) and Plaintiff’s motion to strike and exclude the expert
opinions of Dr. J. Thomas Brenna and Alan Jones (Dkt. 149) are both DENIED
WITHOUT PREJUDICE;2 Defendants’ motion for leave to file (Dkt. 157) is
GRANTED;3 and Defendants’ motion in limine (Dkt. 168) is DENIED AS MOOT.4
Finally, the Court directs counsel to consider that this controversy is
ultimately just an argument over the meaning of a poorly drafted contract. It
remains firmly within the parties’ control to re-negotiate the terms of the
The Court will revisit the propriety of these expert opinions, if necessary, if they are challenged
through motions in limine, filed in advance of the jury trial in accordance with a briefing schedule
that the Court will issue.
2
The Court notes that this motion was allegedly necessitated by counsel for Plaintiff’s unwillingness
to grant opposing counsel a one-day extension to file a response. When counsel are unable to agree
to short extensions of time to file responses, it is evidence of how far they have strayed from the
professionalism that this Court expects, and indeed from the bounds of common courtesy. Both
parties are encouraged to read and practice the civility principles adopted by the United States
District Court for the Eastern District of Michigan, specifically the section detailing Attorney’s
Responsibilities to Other Counsel.
3
As the Court anticipates that the “sword and shield” privilege issues raised in this motion are likely
to be raised again in the context of trial, the Court strongly encourages the parties to re-evaluate
their positions on this question and work together on resolving these issues among themselves.
4
7
Settlement Agreement and thereby avoid the enormous amount of attorney time
and colossal costs of continuing this litigation.
SO ORDERED.
Dated: September 29, 2014
s/Terrence G. Berg
TERRENCE G. BERG
UNITED STATES DISTRICT JUDGE
Certificate of Service
I hereby certify that this Order was electronically submitted on September
29, 2014, using the CM/ECF system, which will send notification to each party.
s/A. Chubb
Case Manager
8
Disclaimer: Justia Dockets & Filings provides public litigation records from the federal appellate and district courts. These filings and docket sheets should not be considered findings of fact or liability, nor do they necessarily reflect the view of Justia.
Why Is My Information Online?